Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Chemerin Receptor

Chemerin receptor constitutes a class of G protein-coupled receptors, primarily comprising CMKLR1 (ChemR23) and GPR1. CMKLR1 is predominantly expressed in dendritic cells, macrophages, and adipocytes, participating in immune responses, cell migration, and energy metabolism regulation. Upon activation of CMKLR1 by chemerin, signalling pathways including G protein activation, β-arrestin recruitment, calcium ion mobilisation, Erk1/2 phosphorylation, and receptor internalisation are initiated, thereby promoting cell migration, gene expression alterations, and cytokine secretion. GPR1 primarily exerts its effects through β-arrestin-mediated signalling pathways, influencing adipocyte function and energy metabolism. Abnormal expression of chemerin receptors is closely associated with inflammation, metabolic disorders, and tumours, making them potential therapeutic targets for related diseases.

Chemerin-9 (149-157) acetate
TP1617L
Chemerin-9 (149-157) acetate, The nonapeptide 149,YFPGQFAFS157 (chemerin-9), corresponding to the C terminus of processed chemerin, retained most of the activity of the full-size protein, with regard to agonism toward the chemerinR.the natural ligand of C
  • $115
In Stock
Size
QTY
Chemerin-9 (149-157) TFA
TP1435
Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, retaining most of the activity of the full protein. Chemerin-9 acts as a ChemR23/CMKLR1 agonist, preventing atherosclerosis whilst inhibiting NLRP3 inflammasome activation and promoting Aβ microglial clearance. It modulates blood pressure and sympathetic nervous system activity via glutamate receptor-mediated ROS production.
  • $98
In Stock
Size
QTY
α-NETA
T61454115066-04-1In house
α-NETA is a potent choline acetyltransferase (ChA) inhibitor and an ALDH1A1 and chemokine-like receptor 1 (CMKLR1) antagonist.Anti-cancer activity,Cholinesterase and acetylcholinesterase (AChE) inhibition,Dose-dependent reduction of body weight and fasting blood glucose levels in STZ-induced diabetic mice,Significantly reduced expression of renal injury markers,May be CEP-9722 can be used for the study of diabetic nephropathy.
  • $30
3-6 months
Size
QTY
ChemR23-IN-1
T633472378640-10-7
ChemR23-IN-1 is a ChemR23 inhibitor that acts on human and mouse ChemR23 with IC50 values of 38 nM and 100 nM, respectively. chemR23-IN-1 is able to block Chemerin-triggered CAL-1 chemotaxis in vitro.
  • $1,520
6-8 weeks
Size
QTY
Chemerin-9 (149-157)
TP1617676367-27-4
The nonapeptide 149,YFPGQFAFS157 (chemerin-9), corresponding to the C terminus of processed chemerin, retained most of the activity of the full-size protein, with regard to agonism toward the chemerinR.the natural ligand of ChemR23 (chemerinR).
  • $627
35 days
Size
QTY
Chemerin-9, Mouse
T37128686324-96-9
Chemokine-like receptor 1 (CMKLR1) agonist (EC50 = 42 nM). Corresponds to C-terminal of full length mouse Chemerin, amino acids 148 - 156.
  • $627
35 days
Size
QTY